Cardiorenal Laboratory
Rogosin’s history can be traced back to 1955 when the first Cardiorenal Laboratory at Bellevue Hospital in New York City was created and became the predecessor for ensuing kidney programs.
First Hemodialysis
Albert L. Rubin (founder of The Rogosin Institute), and his team performed the first hemodialysis in the metropolitan area as a treatment for kidney failure.
Rogosin Renal Laboratories
The “unit,” known as the Renal Laboratory, moved to The New York Hospital, now known as NewYork-Presbyterian Hospital. There it expanded to become the Rogosin Renal Laboratories, named in honor of Israel Rogosin (1886-1971), an American textile industrialist and philanthropist who was a generous benefactor to New York Hospital.
First Kidney Transplant
The first kidney transplant in the metropolitan area was performed by the Rogosin renal group in 1963.
Rogosin Kidney Center
With continued growth of the kidney disease program, The New York Hospital/Cornell Medical Center was designated by the Department of Health of the State of New York as a Regional Kidney Disease Center in 1968 and the laboratories then became formally known as the Rogosin Kidney Center.
Founded as an Independent, Not-For-Profit
The Rogosin Institute was established in New York City in 1983 as an independent, not-for-profit institution for research, treatment, and prevention of kidney disease, with Rogosin Kidney Center as one of its components.
Immunogenetics and Transplantation Laboratory (IGT)
In 1985, The Rogosin Institute established the Immunogenetics and Transplantation Laboratory (IGT), which was one of the first and remains one of the largest solid-organ immunogenetics laboratories in the Northeast. Today, the laboratory continues to provide the highest quality testing to determine compatibility between a patient and a donor and its services are used by many transplant centers.
Growth & Expansion
The 1990s saw continued growth and expansion of The Rogosin Institute with the opening of additional clinical facilities in Queens and Brooklyn. Clinical research activities in NYC expanded to include research in kidney and cardiovascular disease and Rogosin began innovative research efforts.
Home Nocturnal Hemodialysis
Initiation of the home nocturnal hemodialysis training and treatment program.
Polycystic Kidney Disease Center
Launch of the Susan R. Knafel Polycystic Kidney Disease Center in 2002 as one of the only treatment centers for polycystic kidney disease in the Northeast.
Opening of Manhattan West Dialysis
The new Maurice R. & Corinne P. Greenberg Center for Integrative Health at The Rogosin Institute opened on West 54th Street in New York City.
Brooklyn Treatment Facility
A new dialysis treatment and education center opened in East New York, Brooklyn.
Opening of Brooklyn Home Dialysis Treatment and Education Center
A new center dedicated solely to home dialysis training and treatment was opened in Carroll Gardens, Brooklyn.
Bronx Treatment Facility
A new dialysis center opened in the Bronx in collaboration with the Methodist Home for Nursing and Rehabilitation.
Rogosin Institute Today
Rogosin now provides dialysis treatments for over 1600 patients at ten dialysis centers throughout the NYC metropolitan area and cares for over 12,000 patients with chronic kidney disease at three kidney clinic locations in NYC.
Our inpatient facilities at NewYork-Presbyterian/Weill Cornell include The Rogosin Institute Wing for treatment of kidney disease including kidney transplantation; and The Rogosin Institute Dialysis and Apheresis Center. The Rogosin Institute physicians care for patients in all clinical areas of NewYork-Presbyterian Hospital/Weill Cornell including the Clinical Translational Science Center (CTSC).
Rogosin is affiliated with NewYork-Presbyterian Hospital and Weill Cornell Medical College and is an affiliate member of NewYork Presbyterian. Our physicians have appointments at NewYork-Presbyterian Hospital and Weill Cornell Medical College.